4//SEC Filing
Hampton Malcolm Garret 4
Accession 0001127602-18-036231
CIK 0001110803other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:21 PM ET
Size
7.1 KB
Accession
0001127602-18-036231
Insider Transaction Report
Form 4
ILLUMINA INCILMN
Hampton Malcolm Garret
EVP Clinical Genomics Group
Transactions
- Award
Common Stock
2018-12-11+1,901→ 8,101 total - Award
Performance Shares
2018-12-11+5,701→ 5,701 totalExp: 2022-01-02→ Common Stock (5,701 underlying)
Footnotes (2)
- [F1]Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of November 5, 2019, November 5, 2020, November 5, 2021 and November 5, 2022, subject to awardee's continuing status as a service provider on such dates.
- [F2]Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's earnings per share for the fiscal year ending January 2, 2022. The number of shares issued will range from 0% to 150% of the amount specified above, based on the company's actual earnings per share for the fiscal year ending January 2, 2022, relative to pre-defined objectives, subject to awardee's continuing status as a service provider on such dates.
Documents
Issuer
ILLUMINA INC
CIK 0001110803
Entity typeother
Related Parties
1- filerCIK 0001698265
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 6:21 PM ET
- Size
- 7.1 KB